Skip to content

Redefining standard fatigue assessments through novel digital biomarkers

The project team will provide the first digital biomarkers for the objective assessment of fatigue. This will help the pharmaceutical industry to provide new or existing treatments with efficacy claims against fatigue. It will also support clinical decision making and help patients regain control over fatigue. By customizing the tools to the respective needs, the gap between the existing prototype and customer acquisition is closed.

Pietro Oldrati, UZH Institute for Implementation Science in Health Care (IfIS)

Practice partner:

Klinik Hirslanden

Running time: 2024-2025